date:May 04, 2014
a figure of 2.73m, compared to 4.90m in the first quarter of 2013.
Natraceuticals turnover contributed 10.10m to the consolidated Natra figure, compared to 11.15m in the first quarter of 2013 (-10.4%). This adjustment was mainly due to the change in the purchasing dynamics in the pharmaceutical channel, which traditionally acquired its main supply for nutritional weight control supplements during the first quarter pre-sale campaign. As a direct result, and despite a reduction in operating costs